A randomized, double-masked study to evaluate the efficacy of adding nepafenac 0.1% ophthalmic suspension to dexamethasone 0.1% on macular swelling after cataract surgery .
Phase of Trial: Phase IV
Latest Information Update: 10 Sep 2015
At a glance
- Drugs Nepafenac (Primary) ; Dexamethasone
- Indications Cataracts
- Focus Therapeutic Use
- 10 Sep 2015 New trial record